0001479290-18-000095.txt : 20180706 0001479290-18-000095.hdr.sgml : 20180706 20180706211715 ACCESSION NUMBER: 0001479290-18-000095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180706 FILED AS OF DATE: 20180706 DATE AS OF CHANGE: 20180706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Allouche Cyril CENTRAL INDEX KEY: 0001744573 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 18943233 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 4 1 wf-form4_153092621726058.xml FORM 4 X0306 4 2018-07-06 0 0001479290 Revance Therapeutics, Inc. RVNC 0001744573 Allouche Cyril C/O REVANCE THERAPEUTICS, INC 7555 GATEWAY BLVD NEWARK CA 94560 0 1 0 0 Principal Financial Officer Common Stock 2018-07-06 4 S 0 393 28.35 D 4750 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Allouche. /s/ Gordon Ho, Attorney-in-Fact 2018-07-06